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RESEARCH ARTICLE

Abstract
Bovine colostrum (BC) is the first milk produced by cows after calving and contains numerous beneficial substances
for the immunity and development of the newborn calf. Because of the growth and immune factors in BC, it has
become an attractive supplement for use by athletes to support immunity and health during athletic performance.
In order to evaluate the effects of oral BC supplementation on equine athletes, this study evaluated the earnings,
performance, recovery and incidence of upper respiratory infections (URTI) in racing horses. The study design was
a randomized cross-over racing performance study. 21 horses in race training were randomly assigned to train and
compete with or without BC supplementation. After each horse competed in three races, it was crossed over to the
other group, allowed a three week washout period, and then competed in three additional races. Horses in public
training stables of 3 participating trainers were used. Race performance as determined by earnings, Bloodstock
Research Information System (BRIS) speed figures, recovery as determined by number of days between races and
incidence of upper respiratory tract disease was recorded. 11 horses completed the study. There was no effect of
the order of BC supplementation on the measured variables. Horses on BC supplementation earned $ 2,088 more
purse money per race, than when unsupplemented (P=0.016), and ran an average of 5 BRIS speed points higher
(P=0.03). Horses returned to racing on average 7.5 days faster (16.9 days vs 24.4 days, P=0.048). There were no URTI
among the horses on BC supplementation and two infections while not on BC supplementation (z-test, P=0.11).
Statistical analysis showed that horses recovered more quickly, earned three times more money and raced better
as judged by BRIS scores while competing with BC supplementation. BC supplemented horses also experienced
fewer URTI, although this effect was not significant.
Keywords: bovine colostrum, horse, performance, brisnet speed figures, upper respiratory tract infections

1. Introduction
Bovine colostrum (BC) is the first milk produced by
cows after calving. BC contains immunoglobulins, other
immune factors, growth factors and nutrients necessary
for optimal immunity, support and long term performance
of the neonatal calf. More recently, BC has been used as a
nutritional supplement in humans for both immune support
and for optimising athletic performance. In humans, BC

has been shown to be effective in reducing the incidence of
influenza (Cesarone et al., 2007), and upper respiratory tract
infections (URTI) in children (Patel and Rana, 2006), and
in athletes (Brinkworth and Buckley, 2003). In humans, BC
has been found to improve endurance cycling performance
(Coombes et al., 2002) and to enhance recovery and improve
performance following sequential exercise sessions (Buckley
et al., 2002; Shing et al., 2006).
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Horse racing is a highly competitive sport in which trainers
and veterinarians strive to maintain their animals in
optimal health. Dietary supplements that support immune
responses and thereby optimise the health, welfare and
athletic performance of horses are potentially of great
benefit to the racing industry. While the effect of BC dietary
supplementation may be related to reported increases in
plasma immunoglobulin (IGF)-1 in humans (Mero et al.,
1997), no such BC supplementation increases in IGF-1
occurs in horses associated with the BC supplementation
protocol reported herein (Fenger et al., 2014).
Given these considerations, this study was undertaken to
determine if BC has a beneficial effect on the incidence
of URTI and athletic performance in Thoroughbred
racehorses.

2. Materials and methods
Study facilities and animals
Privately owned Thoroughbred racehorses in race training
in Central Kentucky were used throughout. Horses were
housed and trained according to standard racing stable
management procedures at a Thoroughbred training facility
in Lexington, KY, USA. Horses were stabled in 3.7×3.7
m stalls bedded in straw. Training consisted of trotting
approximately 1.6 to 2.4 km (1 to 1.5 miles) and galloping
approximately 1.6 to 2.4 km (1 to 1.5 miles) either on the dirt
racetrack or a turf exercise field five days a week, with about
one breezing day (fast gallop approaching racing speeds
for 0.6 to 1.0 km (3/8 to 5/8 mile) per week and one day of
walking only per week. Races were chosen according to the
standard operating procedures of the 3 trainers involved.
The study protocol was approved by the institutional animal
care and use committee of Equine Integrated Medicine PLC
and for all horses participating in the study, the owner or his
or her designee (i.e. the trainer) provided informed consent.

Bovine colostrum
The colostrum used in this trial was produced under USDA
and CFIA permits for commercial sale as a veterinary
biologic. Excess colostrum was collected from dairies
licensed to produce milk for human consumption and
stored frozen (-18 °C) until processing. The colostrum was
then thawed at room temperature until softened sufficiently
to be pooled following pulverisation by an ice crusher,
then pasteurised using a proprietary method (Saskatoon
Colostrum Company, Ltd., Sasketchewan, Canada)
developed to eliminate pathogenic contaminants while
maintaining the integrity of the immune factors and spray
dried. The spray dried colostrum was tested for retention
of potency using an radial immunodiffusion method for
IgG and for safety using standard microbiological methods
for total plate counts, coliforms and Salmonella. The BC
234

powder was then packaged by Animal Healthcare Products
and Packaging, Inc. (Winchester, KY, USA) according
to good manufacturing practices protocol before being
shipped to the study location.

Experimental design
All racehorses in the three participating trainers’ control
were included in this cross-over study. Trainers were
previously known to one of the investigators (CF) to be
reliable and able to comply with the study procedures.
Horses were randomly assigned to the BC supplementation
first or no BC supplementation first groups. Horses in the
treatment group received 100 g BC daily as a feed top dress
for at least weeks prior to the first race and until 3 races
were completed, at which point they had a 3 week washout
period, followed by three races without BC supplement.
Horses in the no BC supplementation first group had three
races, followed by at least a 3 week acclimation period on
100 g BC daily, which period continued until 3 races were
completed. Horses which were claimed, sold or retired prior
to completing the 6 race regimen were excluded from the
performance data analysis. All horses were included in the
URTI incidence data. Horses that completed the study were
all 3 or 4 year olds, with 3 geldings, a male and 2 females in
the no-treatment first group and four females and a gelding
in the treatment first group.
Because of the differences in racing class, time of year, track
surface and condition, the times or finish positions of the
races were not considered to be useful for analysis. Racing
performance was analysed based on the BRIS speed figure
for each race; Bloodstock Research Information System
(BRIS) speed figures were generated by an independent
organisation (Bloodstock research Information System,
Lexington, KY, USA; www.brisnet.com) and recorded for
each of the six races for each horse. This standardised
number represents a racing score independent of other
factors. The amount of money earned for each race was
similarly recorded. The total amount of money earned was
averaged for each horse for the three races in each group.
Recovery days between races were similarly averaged for
all BC days and all non-BC days for each horse. Layoffs
associated with injuries were excluded from the recovery
data. Upper respiratory tract infections were defined as
a nasal discharge and cough, which was diagnosed by
endoscopy to be due to either lymphoid hyperplasia or
guttural pouch infection.

Data analysis
The analysis of variance for a cross-over design, controlling
for period, sequence, and horse, was fit to the data.
Normality in each of the independent variables was
determined by visual inspection of normality plots and
Anderson-Darling test of normality, and analysed using a
Comparative Exercise Physiology 10 (4)
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general linear model (Proc GLM; SAS Institute, Cary, NC,
USA). When normality assumptions were not fulfilled, the
data were transformed before analysis to appropriately meet
model assumptions. Normality assumptions were met for
the analysis of average BRIS speed figures, money earned
in the treatment and control races, and for the square root
transformed recovery days. F-tests were used to determine
the presence of carryover and sequence effects. Incidence
of URTI was analysed using a z-test.

3. Results
A total of 21 racehorses were originally enrolled in the
study, with 11 horses completing the study. Seven horses
were sold before completing 6 races and 3 were 2 year
olds which never started during the study period. Because
the horse sales and 2 year olds were independent of the
assigned treatment, the 10 horses not contained in the
analysis are considered missing at random and hence are
unlikely to unduly bias the results presented here. Of the
11 horses completing the study, 2 horses were excluded
from the recovery analysis owing to injuries, which affected
the days off between races. An ex-post power study was
performed on the cross-over design used to analyse these
data. Across all response variables, a maximum of 10
horses was necessary for least 80% power, hence the 11
horses considered in this study is sufficient for average
horse effects. Further studies, using a greater number of
horses, would be required to find different effects of bovine
colostrum across genders. However, gender stratification
is shown in the figures to demonstrate that there appears
to be no difference between genders.

8,000

A standard linear, normal model was fit to the data using
the appropriate analysis of variance model for a cross-over
design, controlling for period, sequence, and horse. For each
response variable we investigated departures from normality
with both visual inspections and an Anderson-Darling test
of normality. Neither earnings nor BRIS numbers deviated
from the assumption of normality, however, Recovery (days
between races) failed the normality test, so a square root
transformation was performed before analysis. No response
variable showed a sequence effect (earnings, P=0.48; BRIS
numbers, P=0.12; recovery, P=0.33) or carry-over effect
(earnings, P=0.16; BRIS numbers, P=0.53; recovery, P=0.24),
thus suggesting our cross-over model is not inappropriately
fit to these data. Earnings were higher (P=0.016) with least
squares means of $ 3,241 for horses while receiving BC
supplementation compared to $ 1,153 for horses while not
on BC (Figure 1). The data also show an improvement in
speed (BRIS number, P=0.03) with horses running a least
squares mean of 67 while racing on BC and 62 when not
on BC (Figure 2). Horses also returned to racing 7.5 days
quicker (16.9 days vs 24.4 days, P=0.048) while supplemented
with BC (Figure 3). In this study, no statistically significant
effect of BC supplementation could be identified on the
incidence of URTI (P=0.11), likely because of the small
number of test animals and the relatively small incidence
of overt URTI in this cohort.

4. Discussion
Our data demonstrated a clear improvement in athletic
performance in horses receiving BC supplementation.
Horses raced faster (higher BRIS speed figures) with

Filly
Gelding
Male

80

6,000

Filly
Gelding
Male

60
BRIS

Earnings

https://www.wageningenacademic.com/doi/pdf/10.3920/CEP140023 - Monday, October 28, 2019 10:43:29 AM - University of Kentucky IP Address:128.163.8.74



4,000

40

2,000

20

0

0
no BC

Treatment

BC

Figure 1. Average race earnings (US$, P=0.016) for all horses
with or without bovine colostrum (BC) supplementation
(randomly jittered along the x-axis for clarity). The horizontal
bars across each treatment represents the least squares mean
as predicted by the model fit to the data shown.
Comparative Exercise Physiology 10 (4)
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Figure 2. Average BRIS speed ratings (P=0.03) for all horses with
or without bovine colostrum (BC) supplementation (randomly
jittered along the x-axis for clarity). The horizontal bars across
each treatment represents the least squares mean as predicted
by the model fit to the data shown.
235

C.K. Fenger et al.

50

been reported (Coombes et al., 2002), and a recent study
found increased leg press strength when older adults were
supplemented with BC (Duff et al., 2014).
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Figure 3. Average recovery days between races for the
second and third races with or without bovine colostrum (BC)
supplementation for all horses (randomly jittered along the
x-axis for clarity). The horizontal bars across each treatment
represents the least squares mean as predicted by the model
fit to the data shown. Two horses were excluded from analysis
because of illness or injury. Statistical analysis was performed
on transformed data (P=0.048), but non-transformed data are
shown here.

aggregate greater earnings of $ 70,455 over the course
of this study while supplemented with BC. BRIS speed
figures are calculated based on a computed algorithm
which takes into account racetrack, surface, track condition,
quality of the other horses in the race, and other factors
contributing to the racing performance of a horse in a given
day (www.brisnet.com). This is a performance metric which
is comparable across all races on all days and is computed
for all horses in North America. BRIS speed figures translate
into approximately 1 point per 1-1.5 lengths in a race,
with the value of a length decreasing as the race distance
increases to accurately reflect racing effort. Therefore, the
5 BRIS speed figure improvement in racing performance in
horses on BC supplementation reflects an approximately
5 length improvement in racing performance.
The performance effects of dietary supplementation
with BC in human athletes is mixed. No improvement
in performance was seen in a small double-blind study in
healthy men and women undergoing aerobic and resistance
training (Antonio et al., 2001), although there was an
increase in lean body mass. Similarly, no performance
effect was seen in endurance exercise in male and female
hockey players (Hofman et al., 2002), rowing ability in
elite female rowers (Brinkworth et al., 2002), or a single
exercise-to-exhaustion test (Buckley et al., 2002). On the
other hand, a small improvement in a 2 h endurance time
trial in cyclists after an 8-week supplementation period has
236

The mechanism of athletic performance improvement in
humans has not been determined, but has been suggested to
be associated with an increase in serum IGF-1 concentration
(Mero et al., 1997). However, the magnitude of the increase
of IGF-1 seen in the Mero study was small, did not exceed
the normal range, and has not been repeatable by other
investigators (Buckley et al., 2002; Coombes et al., 2002;
Duff et al., 2014). Similarly to these latter studies, there
is no increase in IGF-1 in Thoroughbred race horses
associated with BC supplementation (Fenger et al., 2014).
This indicates that any improvement in performance seen
with BC in these horses was independent of an IGF-1 effect.
One possible mechanism could be related to other cytokines
in BC, such as interleukin (IL)-1β, IL-6, tumour necrosis
factor alpha (TNF-α), interferon-gamma (INF-γ) and IL-1
receptor antagonist (IL-1ra), any of which may have an
effect on athletic performance. While most cytokines would
typically be degraded in the digestive tract, it has been
suggested that cytokines in BC may be protected by some
unidentified mechanism, resulting in their survival through
the digestive process and absorption into the circulation
(Davison, 2012). The role of inflammatory cytokines, such
as IL-1β, IFN-γ, IL-6 and TNF-α during exercise is to send
critical signals to exercising muscles that reactive oxygen
species and other indicators of stress are forthcoming.
These critical signals set off a cascade of reactions mediated
by nuclear factor kappa-beta (NF-κβ), which moderates
adaptation to exercise (Radak et al., 2013). If these cytokines
are absorbed from the BC, then this adaptation may be the
mechanism of the improved performance during exercise.
Post-exercise recover y was improved with B C
supplementation in our subjects. Horses were able to race
back 7.5 days quicker, reflecting a shorter recovery time after
a maximal racing effort in our study. This is a similar finding
to studies in humans. In an 8-week, double-blinded, placebocontrolled study, BC supplementation did not improve
performance on an exercise-to-exhaustion test. However,
it did improve performance on a repeat test 20 min later
(Buckley et al., 2002). In cyclists performing high intensity
exercise tests with short recovery times, BC supplementation
also benefitted recovery (Shing et al., 2006). The improved
recovery may be the result of a reduction in oxidative stress
in skeletal muscle during exercise while supplemented with
BC (Appukutty et al., 2013).
In our study, there was no difference in incidence of overt
URTI in horses while BC supplemented. However, this
was likely due to an overall low rate of overt URTI in this
cohort. In humans, BC supplementation decreased the
incidence of influenza (Cesarone et al., 2007), URTI in
Comparative Exercise Physiology 10 (4)
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children (Patel and Rana, 2006), and in athletes (Brinkworth
and Buckley, 2003). Intense exercise training is well known
to cause immunosuppression in humans (Smith, 2003) and
horses (Davis et al., 2007) which can manifest as URTI. This
has been suggested to result from a suppression of TH-2
cell-mediated immunity by an exercise related increase
in the TH-1 immune response (Smith, 2003), and an
increase in natural killer (NK) cells (Wong et al., 2014). In
human studies, BC supplementation has multiple immune
system effects in athletes, including increasing salivary
immunoglobulin A concentrations in runners (Crooks et al.,
2006), improvement in the recovery of neutrophil function
and maintenance of salivary lysozyme concentrations in
cyclists (Davison and Diment, 2010), and preventing the
TH-2 immune suppression associated with exercise in
cyclists (Shing et al., 2007). While our URTI data did not
attain statistical significance, the overall incidence of overt
URTI was low in our group. This was likely the result of the
requirement of the crossover model for 6 or 7 sequential
races. Often, younger horses, which are more susceptible to
overt URTI, fail to make this number of races sequentially
without substantial layoffs. Nonetheless, the only overt
URTI were in the horses during the non-BC supplemented
period, and it is likely that subclinical infection also occurs,
which may have detrimental performance effects. The
mechanism of decreased incidence of URTI in athletes
supplemented with BC is likely associated with an immune
modifying effect of the BC supplementation, presumably
offsetting the transient immunosuppression associated with
intense exercise. An immune modifying effect may have
influenced performance and recovery in this study, although
this cannot be unequivocally shown with these data.
The horse is physiologically unique in that as soon as it
begins to exercise it fails to fully oxygenate its blood (Fenger
et al., 2000), suffering from ‘exercise induced hypoxemia’.
The stroke volume of blood travels so rapidly across the
pulmonary circulation that there is insufficient time for
complete oxygenation across the thin alveolar-capillary
membrane. Inflammation in the airways as may be caused
by subclinical infection acts to exacerbate ‘exercise induced
hypoxemia’ in horses, by thickening this alveolar-capillary
membrane. Demonstrating this phenomenon, Sánchez et
al. (2005) showed that the faster a horse runs the greater
the oxygen deficit in the blood delivered to the muscles,
and that this deficit is exacerbated by airway inflammation.
Any intervention that reduces airway inflammation may
be expected to immediately and proportionally improve
oxygen delivery to the exercising musculature and thus
equivalently improve racing performance, and may have
been the mechanism of the performance benefit seen in
the present study.
In conclusion, BC can be supplemented to racehorses
for the purpose of optimising athletic performance and
recovery of the animal. Further studies to elucidate the
Comparative Exercise Physiology 10 (4)

optimal dose, extent and specific mechanisms of immune
modifying effect of BC in exercising horses are warranted.
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